Matrix metalloproteinases in pathophysiology and treatment of heart failure

Lancet

Volumn 357, Issue 9257, 2001, Pages 654-655

  Feldman, A M ^a   Li, Y Y ^a   McTiernan, C F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

CROSS LINKING; ENZYME INHIBITION; ENZYME SUBSTRATE; EXTRACELLULAR MATRIX; HEART FAILURE; HUMAN; NOTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0035799101     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04151-9     Document Type: Note

References (16)

1. Ueber die trophospongien der quergestreiften muskelfasern, nebst bemerkungen uber den allgemeinen bau dieser fasern
2. The collagen matrix of the heart
3. Cardiac interstitium in health and disease: The Fibrillar Collagen Network
4. Myocardial matrix degradation and metalloproteinase activation in the failing heart: A potential therapeutic target
5. Inadequate collagen tethers in dilated cardiomyopathy
6. Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy: Role of metalloproteinases and pyridinoline cross links
7. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling
8. Matrix metalloproteinases and cardiovascular disease
9. Time-dependent changes in matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy
10. Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor-a can be modulated by anti-tumor necrosis factor-a therapy
11. Differential expression of tissue inhibitors of metalloproteinases in the failing human heart
12. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy
13. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure
14. Matrix metalloproteinase inhibition during the development of congestive heart failure. Effects on left ventricular dimensions and function
15. Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice
16. Prospects for medical intervention in cartilage repair